European scientists tested a vaccine to inhibit the cholesterol-related enzyme PCSK9 and reported promising results in mice.
A new molecule may shed light on how synaptic imbalances happen and improve understanding of neurological conditions.
How PAREXEL's New Ecosystem of Technology, Processes and Expertise is Transforming Drug Development
A Rutgers University-led team has discovered a new antibiotic that could work against bacteria that have developed drug resistance.
Scientists at Beth Israel Deaconess Medical Center are discovering why the process of feeling too full to eat any more goes awry in some people.
With pressures to fast-track clinical development, the pharmaceutical industry recognizes the value of improving internal clinical data management processes.…
Researchers from the Washington University School of Medicine found that injecting trehalose, a naturally occurring sugar, reduced arterial plaque in mice.
Massachusetts General Hospital scientists have evidence that a TB vaccine prevents the immune system from attacking normal tissues.
A new snake venom-based antiplatelet drug could avoid excessive bleeding associated with other antiplatelet meds.
Scientists led by Duke University believe they've found a way to improve upon RV144, an early HIV vaccine that was just 31% effective in trials.
British researchers kicked up some buzz at the American Society of Clinical Oncology annual meeting on June 3 with positive results from a phase 1 trial in…
German scientists have discovered a new “off-switch" for the mTor pathway, which could lead to new diabetes therapies.